Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri – Russia, 2019-10-28 09:13 (357 d 21:01 ago) – Posting: # 20727
Views: 1,819

(edited by mittyri on 2019-10-28 11:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,164 posts in 4,410 threads, 1,476 registered users;
online 12 (1 registered, 11 guests [including 11 identified bots]).
Forum time: Tuesday 06:14 UTC (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5